Litigation Details for Vifor Fresenius Medical Care Renal Pharma Ltd. v. Annora Pharma Private Limited (D. Del. 2018)
✉ Email this page to a colleague
Vifor Fresenius Medical Care Renal Pharma Ltd. v. Annora Pharma Private Limited (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-12-17 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | Referred To | ||
| Patents | 9,561,251 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vifor Fresenius Medical Care Renal Pharma Ltd. v. Annora Pharma Private Limited
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Vifor Fresenius Medical Care Renal Pharma Ltd. v. Annora Pharma Private Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-04-30 | 69 | Order - -Memorandum and Order | the disputed claim terms of U.S. Patent No. 9,561,251 (“the ’251 Patent”) are construed as follows: …in this case, we have one patent, U.S. Patent No. 9,561,251, and three terms in dispute… the entire patent.” Id. at 1321 (internal quotation marks omitted). The patent specification…251 Patent, the portions of the prosecution history submitted, the related patent …[7] 2 (’251 Patent at 5:31-34). 3 (See, e.g., ’251 Patent at Examples 1a-c, which | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
